Overseas markets trended lower after long weekend

Published 31-MAY-2017 10:46 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

In the first day of trading after the long weekend US and UK markets trended downwards with the Dow coming off 0.2% to close at 21,029 points after slumping to a low of 21,009 points just after the open.

The NASDAQ only fell slightly to 6203 points amid solid performances from stocks in the tech sector.

European markets were unsettled by ructions surrounding the election in Italy, as well as renewed volatility in Greece.

However, there weren’t any sector specific moves of note, and the slight pullback could be attributed to profit-taking particularly after the recent strong run which saw the FTSE 100 hit record highs last week.

The index closed 0.3% lower at 7526 points, still up circa 300 points or 4% in the last month.

It was a similar story in mainland Europe as major indices, the DAX (-0.2%) and the Paris CAC 40 (-0.5%) continued to pull back from recent highs.

The DAX closed at 12,598 points and the Paris CAC 40 retraced to 5305 points. Of the three indices, the Paris CAC 40 has lost the most ground in the last few weeks, and is trading in line with its one month low.

However, to put this in perspective the index rallied hard leading up to the French presidential election, increasing from approximately 5000 points to more than 5400 points, so in effect it has held on to circa 75% of those gains.

On the commodities front, oil came off slightly to close at US$49.65 per barrel after briefly touching US$50 per barrel in the previous session.

Gold briefly pushed above US$1270 per ounce in early trading, a crucial move given technical analysts see further upside should the precious metal close above that mark. However, that didn’t eventuate as it closed at US$1265 per ounce.

Iron ore was relatively unmoved at US$58.50 per tonne.

There were only minor movements in base metal prices with trading fairly subdued as May draws to a close.

However, it is worth looking at monthly moves. At US$2.55 per pound, copper is off approximately 1% for the month.

Nickel has slumped from US$4.26 per pound at the start of the month to US$4.10 per pound.

After suffering a sharp mid-month dip, zinc has recovered most of the lost ground and is trading in line with where it started the month at US$1.18 per pound.

Lead has been the hardest hit, falling from US$1.03 per pound to an intra-month low of US$0.93 per pound. The slight recovery to US$0.95 per pound still implies a fall of nearly 8% for the month.

The Australian dollar strengthened slightly and is currently fetching US$0.746.

This article is General Information and contains only some information about some elements of one or more financial products. It may contain; (1) broker projections and price targets that are only estimates and may not be met, (2) historical data in terms of earnings performance and/or share trading patterns that should not be used as the basis for an investment as they may or may not be replicated. Those considering engaging with any financial product mentioned in this article should always seek independent financial advice from a licensed financial advisor before making any financial decisions.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X